… Read More
Despite attempts by some lawmakers to ban red-light cameras, the village of Palatine — like others across the suburbs — plans to continue using them, although it has solicited proposals from vendors rather than automatically extending its latest contract.
The cameras have worked well for the village, lowering traffic crashes and increasing safety, Palatine Village Manager Reid Ottesen said. They’ve also brought in millions of dollars in revenues earmarked for the police department, particularly its traffic unit.
The village has no complaints about its vendor since 2008, RedSpeed Illinois, but it’s doing due diligence by seeking other proposals, Ottesen said. The latest contract ended in July and is continuing on a month-to-month basis.
“The industry has evolved …” he said. “I really felt we should look far and wide to see what’s out there. Are we getting the best value? Are we getting the best equipment? Those are the things
… Read More
Calix selects Conexon as the first Elite Partner in the consulting category of the Calix Partner Community, aligning both organizations around the urgent need to deliver broadband to underserved rural communities throughout the U.S.
Calix, Inc. (NYSE: CALX) today announced a formal partnership with full-service broadband consulting firm, Conexon, which it has named an Elite Consulting Engineering Partner, the founding member of the consulting category of the Calix Partner Community. The terms of the relationship provide Conexon customers access to the entire Calix product portfolio—both Revenue EDGE and Intelligent Access EDGE solutions, along with the full set of Calix Services—which means electric cooperatives that work with Conexon can also leverage Calix solutions to build future-proof networks that will help their communities thrive for decades to come.
Currently more than a quarter of the 800-plus electric cooperatives serving rural areas are deploying broadband services, and the federal government has made billions
… Read More
The CRISPR/Cas9 gene-editing tool is one of the most promising approaches to advancing treatments of genetic diseases – including cancer -, an area of research where progress is constantly being made.
Now, the Molecular Cytogenetics Unit led by Sandra Rodríguez-Perales at the Spanish National Cancer Research Centre (CNIO) has taken a step forward by effectively applying this technology to eliminate so-called fusion genes, which in the future could open the door to the development of cancer therapies that specifically destroy tumors without affecting healthy cells. The paper is published in Nature Communications.
Fusion genes are the abnormal result of an incorrect joining of DNA fragments that come from two different genes, an event that occurs by accident during the process of cell division. If the cell cannot benefit from this error, it will die and the fusion genes will be eliminated.